Imbruvica is part of the Kinase Inhibitors class and treats Chronic Graft Versus-Host Disease and Non-Hodgkin Lymphoma. Kinase inhibitors are used to treat cancers such as leukemia, breast cancer, melanoma, lung cancer, and renal cancer. They are also used to prevent organ transplant rejection. They work by stopping cancer cell growth and preventing the spread of the cells. Imbruvica is only available as a brand name drug.

With the Patient Assistance Program from PAN Foundation, contact the program to see how they can financially help you out.